Home » Posts tagged with » Sanford J. Madigan
Merck acquires Calporta Therapeutics from COI Pharmaceuticals

Merck acquires Calporta Therapeutics from COI Pharmaceuticals

Merck acquisition of Calporta : Merck has acquired Calporta Therapeutics from COI Pharmaceuticals in a deal worth up to $576 million, as per the latest pharma acquisition news. Calporta Therapeutics, which was launched in early 2015, is engaged in the development of selective small-molecule agonists to TRPML1. According to COI Pharmaceuticals, TRPML1 is thought to […]